Terconazole Vaginal Suppository
Sponsors
Padagis LLC, Peking University Shenzhen Hospital, Hatem AbuHashim
Conditions
Vulvovaginal Candidiasis
Phase 4
Unknown Phase
Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis
CompletedNCT00803738
Start: 2002-12-31End: 2003-12-31Updated: 2021-10-13
Comparison of Boric Acid vs. Terconazole in Treatment of RVVC
NCT04208555
Start: 2020-01-15End: 2021-05-31Target: 76Updated: 2019-12-24